Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited
Company Summary
Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited was set up on Monday the 20th of April 2015. Their current partial address is Dublin, and the company status is Liquidation. The company's current directors have been the director of 1 other Irish company between them; 1 of which is now closed. Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited has 1 shareholder. This Irish company shares its Eircode with at least 424 other companies.
Company Vitals
- Company Name:Glaxosmithkline Consumer Healthcare Investments (Ireland) (No 3) Limited
- Time in Business:9 Years
- Company Number:560724
- Current Status:Liquidation
- May Trade As:Glaxosmithkline Consumer Healthcare Investments Ireland No 3 Ltd
- Size:Micro Company
- Principal Activity:Financial Intermediation, Except Insurance and Pension Funding
- Partial Address:Dublin
Documents
| Document | Pages | Effective | Received |
|---|---|---|---|
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 6 | 21/06/2024 | 25/06/2024 |
| Form E3: Liquidator`s Accounts of Acts & Dealings | 3 | 21/12/2023 | 04/01/2024 |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 6 | 21/12/2023 | 04/01/2024 |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 6 | 21/06/2023 | 20/10/2023 |
| Form E3: Liquidator`s Accounts of Acts & Dealings | 3 | 21/12/2022 | 04/01/2023 |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 5 | 21/12/2022 | 04/01/2023 |
| Form E2: Notice of Appointment of Liquidator(s) | 1 | 22/12/2021 | 23/12/2021 |
| E1-SAP Declaration of Solvency Summary App Procd | 4 | 13/12/2021 | 23/12/2021 |
| Form B1C - Annual Return General | 4 | 30/09/2021 | 25/11/2021 |
| Constitution | 8 | 18/11/2016 | 29/11/2016 |
This company has 49 other documents.